VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
199,106MODERNA
36,710JANSSEN
5,381PFIZER\BIONTECH
2,555GLAXOSMITHKLINE BIOLOGICALS
1,469UNKNOWN MANUFACTURER
897MERCK & CO. INC.
627SEQIRUS, INC.
112DYNAVAX TECHNOLOGIES CORPORATION
91SANOFI PASTEUR
75NOVARTIS VACCINES AND DIAGNOSTICS
40EMERGENT BIOSOLUTIONS
14PAXVAX
12TEVA PHARMACEUTICALS
12PROTEIN SCIENCES CORPORATION
9PFIZER\WYETH
4BERNA BIOTECH, LTD.
4SMITHKLINE BEECHAM
3INTERCELL AG
1MEDIMMUNE VACCINES, INC.
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL7,949
7,473
2,547
1,506
1,187
1,051
1,049
s0294561,043
866
IMM209861
816
UT7065MA766
657
579
U62828AA563
557
538
U6737AA516
515
S034636506
4F472471
458
P100253275449
444
276563436
429
418
4BH32414
MENVEO404
PP9L5362
UJ446AA337
319
306
290
271
49TM3270
R1B252M253
4F472179
933622147
C5763AA144
CW3116134
3Y7NL126
UNK114
113
ARBA141A105
104
103
96
300057A90
79
1F4EB73
R1B743M62
56
UJ090AA55
51
UH894AB46
45
UNK44
UNK42
42
EJ168638
Unknown36
35
34
32
32
26
el128424
24
A115A22
22
EN620222
21
UNK20
20
19
Z127A19
19
17
JEV18K95E15
12
111798PI12
10
A739088
No batch number8
3333324181078
6
6
TAR356
5
5
U6935AA5
UNK5
4
unknown4
3
2
55RB72
2
2
2
2
2
U7124AA2
JEV18A68E2
2
ABYB05BA1
1
1
1
1
AMVA436A1
1
1
TJ3521
A130A; VIS give1
1
U7140BB1
1
1
SP UP016AA1
1
1808P08802/ESV01
037K20A300,947
EL1284288,578
57,766
1,432

Incidents per State

State Total
82,750
CA62,821
FL38,209
TX36,512
NY34,921
PA23,646
IN23,622
IL20,597
MI19,590
OH19,426
NJ18,413
NC16,769
GA15,932
WA15,351
VA15,234
MA14,876
AZ14,206
MN12,940
MD12,656
CO11,908
WI11,425
MO10,240
TN9,685
OR8,768
KY8,437
CT8,300
SC6,700
OK6,293
AL5,692
LA5,025
IA4,825
KS4,821
UT4,637
NV4,374
NM3,967
AR3,807
ME3,161
NH3,096
NE2,918
MS2,859
ID2,785
WV2,469
HI2,459
PR2,417
MT2,414
RI2,076
DE1,868
AK1,830
VT1,734
DC1,715
ND1,388
SD1,269
WY866
GU118
VI69
AS47
MP29
MH8
XB6
FM4
QM3
XV2
XL1

ID: 1827956
Sex: F
Age:
State: GA

Vax Date: 05/08/2021
Onset Date: 05/08/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: Became very ill; Chills; Headache; Nausea; Body aches; Lethargic/did not get out of bed; Loss of appetite; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 08May2021 at 09:00 (at the age of 51-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 08May2021 at 19:00, within 10 hours after taking the second dose of the vaccine, the patient became very ill. The patient experienced chills, headache, nausea, body aches, lethargic, loss of appetite and did not get out of bed. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the events. The clinical outcome of the events became very ill, chills, headache, nausea, body aches, lethargic, loss of appetite and did not get out of bed was recovering at the time of report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1827957
Sex: F
Age:
State: KY

Vax Date: 04/17/2021
Onset Date: 04/17/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: Headache; Muscle pain in armpits; muscle pain ~4 inches from injection site; Loss of smell for 2 hrs; loss of taste for 2 hrs; Body aches; Malaise; Approx 30 minutes after vaccine got intense wave ofnausea; Approx 30 minutes after vaccine got intense wave oflightheadedness; Almost passed out; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the left arm on 17Apr2021 at 14:30 (at the age of 33-year-old), as a single dose for COVID-19 immunisation. Medical history included asthma and COVID-19 and known allergy to penicillin. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included levocetirizine dihydrochloride (XYZAL), bupropion hydrochloride (WELLBUTRIN), montelukast sodium (SINGULAIR), salbutamol (VENTOLIN), fluticasone propionate, salmeterol xinafoate (WIXELA INHUB) and sp (as reported); all for unknown indication from an unknown date and unknown if ongoing. The patient previously received amoxicillin (MANUFACTURER UNKNOWN), levofloxacin (LEVOQUIN), doxycycline (MANUFACTURER UNKNOWN) and paracetamol; oxycodone hydrochloride (PERCOCET); all for unknown indication from an unknown date and experienced drug allergy. On 17Apr2021 at 15:15, the patient experienced headache, muscle pain in armpits, muscle pain approximately 4 inches from injection site (felt like muscle tearing), loss of smell and taste for 2 hours, body aches, malaise. Approximately 30 minutes after vaccine, the patient got intense wave of nausea, light-headedness and almost passed out. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events loss of smell and loss of taste was resolved on 17Apr2021, after the duration of approximately 2 hours. The clinical outcome of the events headache, muscle pain in armpits, muscle pain 4 inches from injection site, body aches, malaise, intense wave of nausea, lightheadedness and almost passed out was resolved on an unspecified date in 2021. No follow-up attempts are needed. No further information is expected.

Other Meds: XYZAL; WELLBUTRIN; SINGULAIR; VENTOLIN [SALBUTAMOL]; WIXELA INHUB

Current Illness:

ID: 1827958
Sex: F
Age:
State: CO

Vax Date: 05/11/2021
Onset Date: 05/11/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: Immediately had a persistent metallic taste in my mouth; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 11May2021 at 12:00 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included levothyroxine sodium (LEVOTHYROXIN) from an unknown date, for unknown indication and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received prochlorperazine maleate (COMPAZINE) on an unknown date, for unknown indication and experienced drug allergy. On 11May2021 at 12:00, the patient immediately had a persistent metallic taste in the mouth. The event did not result in a doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event immediately had a persistent metallic taste in mouth was not resolved at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: LEVOTHYROXIN

Current Illness:

ID: 1827959
Sex: F
Age:
State: VA

Vax Date: 04/21/2021
Onset Date: 05/04/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data: Test Date: 202105; Test Name: Blood test; Result Unstructured Data: Test Result:UNKNOWN RESULTS; Test Date: 20210430; Test Name: Nasal Swab; Test Result: Negative

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: Rash on face specifically cheeks, nose, and between eyes on forehead.; Red, puffy, small bumps, and a little itchy.; Red, puffy, small bumps, and a little itchy; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736) via an unspecified route of administration in the left arm on 21Apr2021 at 14:00 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Medical history included known allergies to opioid pain killers. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any concomitant medication. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 04May2021 at 15:00, the patient experienced rash on face specifically cheeks, nose and between eyes on forehead and red, puffy, small bumps, and a little itchy. On 30Apr2021, the patient underwent COVID-19 virus test via nasal swab and the result was negative. On an unknown date in May2021, the patient underwent blood test and the result was unknown. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of events and included treatment with steroid cream. Since the vaccination, the patient had been tested for COVID-19. The clinical outcome of the events rash on face specifically cheeks, nose and between eyes on forehead and red, puffy, small bumps, and a little itchy was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1827960
Sex: M
Age:
State: CA

Vax Date: 04/26/2021
Onset Date:
Rec V Date: 10/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: I have a rash all over my body but especially on both legs; the rash and swelling became much more serious; the rash and swelling became much more serious; Had a bad reaction; This is a spontaneous report from a contactable consumer (patient). A 77-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EW0172), via an unspecified route of administration, administered in Arm Right on 26Apr2021 (at the age of 77-year-old) as dose 1, single for covid-19 immunisation. Medical history included diabetes mellitus (Verbatim: Diabetes), hypertension (Verbatim: High Blood Pressure), blood cholesterol increased (Verbatim: High cholesterol), asthma (so I am taking some inhalers and I take Levothyroxine), thyroid (Verbatim: Thyroid). Concomitant medication(s) included levothyroxine taken for an unspecified indication, start and stop date were not reported. Caller stated that he had a bad reaction from vaccine. He has a rash all over his body but especially on both legs. He stated he was experiencing some rash in his legs before that (Covid Vaccine), maybe one week before but after that, the rash and swelling became much more serious. As a part of treatment consumer stated he was using over the counter Gold Bond Diabetes Rash Lotion, it is a lotion and he just apply 4 or 5 times a day and cover his entire leg with the lotion. The outcome of events was unknown. No follow-up attempts are needed. No further information is expected.

Other Meds: LEVOTHYROXINE.

Current Illness:

ID: 1827961
Sex: F
Age:
State:

Vax Date: 05/06/2021
Onset Date: 05/06/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: Nauseous and vomiting; Nauseous and vomiting; Hip pain; Chills; Dizziness; Disorientation; This is a spontaneous report from a non-contactable consumer, the patient. A 37-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in left arm on 06May2021 at 12:45 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included montelukast (MANUFACTURER UNKNOWN), loratadine (MANUFACTURER UNKNOWN) and etynodiol diacetate / ethinylestradiol (KELNOR) for unknown indication from an unknown date and unknown if ongoing. The patient previously received paracetamol (TYLENOL) for unknown indication on an unknown date and experienced drug allergy. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 15Apr2021 at 14:15 (age at vaccination-unknown) as a single dose for COVID-19 immunisation. On 06May2021, at 22:00, the patient experienced nauseous, vomiting, hip pain, chills, dizziness and disorientation. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events of nauseous, vomiting, hip pain, chills, dizziness and disorientation were recovering at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: LORATADINE; MONTELUKAST; KELNOR

Current Illness:

ID: 1827962
Sex: F
Age:
State:

Vax Date: 05/07/2021
Onset Date: 05/07/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: Huge red mark around where got the shot; Itchiness everywhere beginning 30 minutes after vaccination; Rashes appearing on thighs and stomach within 24 hours and worsening around 30 hours; This is a spontaneous report from a non-contactable consumer, the patient. A 23-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 07May2021 at 12:00 (at the age of 23-years-old) as a single dose for COVID-19 immunisation. Medical history included allergies to latex and gluten. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive other vaccines within 4 weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 27Apr2021 at 12:30 (at the age of 23-years-old) as a single dose for COVID-19 immunisation. On 07May2021 at 12:30, 30 minutes after vaccination, the patient experienced itchiness everywhere. On 07May2021, within 24 hours, she experienced rashes appearing on thighs and stomach and worsening around 30 hours. On 07May2021 at 13:30, the patient had huge red mark around where she got the shot. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events itchiness everywhere, rashes appearing on thighs and stomach and huge red mark around where she got the shot was not resolved at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1827963
Sex: F
Age:
State:

Vax Date: 04/27/2021
Onset Date:
Rec V Date: 10/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: Experiencing 3 lymph nodes near left collar bone; This is a spontaneous report from a contactable consumer, the patient. A 28-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the left arm on 27Apr2021 (at the age of 28-year-old), as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient did not receive any concomitant medication. On an unknown date in 2021, after taking the vaccine, the patient was experiencing 3 lymph nodes near the left collar bone. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event experiencing 3 lymph nodes near left collar bone was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1827964
Sex: F
Age:
State: PA

Vax Date: 05/01/2021
Onset Date: 05/01/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: Small rash broke out on back and arms. The rashlooks almost like bumps right before a pimple forms, small and hard, extremely tiny. Not very red. Sporadic around my back only a few down each arm.; At injection site there was a burning sensation a little while after leaving facility; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0175) via an unspecified route of administration in the left arm on 01May2021 at 12:30 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history included seizure and known allergy to sulfa. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included lamotrigine (LAMICTAL) and topiramate (MANUFACTUER UNKNOWN); all for unknown indications, from unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01May2021, the patient experienced at injection site, there was a burning sensation a little while after leaving facility. On 06May2021, 5 days later, the patient had small rash broke out on back and arms and the rash looked almost like bumps right before a pimple forms, small and hard, extremely tiny, not very red. It was sporadic around back and only a few down each arm. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events at injection site there was a burning sensation a little while after leaving facility, small rash which broke out on back and arms and the rash looked almost like bumps right before a pimple forms, small and hard, extremely tiny, not very red, sporadic around back and only a few down each arm was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: LAMICTAL; TOPIRAMATE

Current Illness:

ID: 1827965
Sex: F
Age:
State: WA

Vax Date: 04/16/2021
Onset Date: 04/19/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: 3 itchy red spots at "my" inguinal region near lymph nodes/ this rash developed further covering full body,centering around inguinal and armpit areas, legs too/ diagnosed as by "my" dermatologist as gianotti-crosti syndrome, caused by vaccine shot.; This is a spontaneous report from a non-contactable consumer, the patient. A 34-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 16Apr2021 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. The medical history included allergy to dust mites and pollen. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medications were not reported. On 19Apr2021, after 3 days of first Pfizer vaccine shot, the patient developed 3 itchy red spots at her inguinal region near lymph nodes. On 24Apr2021, on 8th day, that rash developed further covering full body, centering around inguinal and armpit areas and legs too. On 25Apr2021, on 9th day, the patient went to see urgent care. On 26Apr2021, 10th day, the patient saw her family doctor and confirmed it was caused by COVID-19 vaccine and prescribed medicine and cream. On 27Apr2021, on 11th day, it was diagnosed as gianotti-crosti syndrome by her dermatologist, caused by vaccine shot. The patient reported that she was recommended to take the second shots by both family doctor and dermatologist, so she went to receive her second shot 3 weeks later, on May7th as planned. The adverse event resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures taken as a result of the reported events included treatment with cetirizine hydrochloride (ZYRTEC), diphenhydramine hydrochloride (BENADRYL), clobetasone cream (MANUFACTURER UNKNOWN) and hydroxyzine (MANUFACTURER UNKNOWN) on unknown dates. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events 3 itchy red spots at inguinal region near lymph nodes, full body rash on inguinal, armpit areas and legs and gianotti-crosti syndrome were resolving at the time of this report. The patient also received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0182) via an unspecified route of administration in the left arm on 07May2021 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1827966
Sex: U
Age:
State:

Vax Date: 05/05/2021
Onset Date: 05/01/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: severe stomach cramps; Dry heaves; Low back pain; sweating, drenched with chills; sweating, drenched with chills; Leg cramps; mild sore throat; loss of appetite; Neck pain; Nauseated; face felt itchy, numbness around chin and cheek; face felt itchy, numbness around chin and cheek; very tired, felt like hit by mack truck, no energy; very tired, felt like hit by mack truck, no energy; couldn't hold anything down; woke every 45 minutes; Headache; nothing to eat the following day and felt horrible; thought it was the flu or Covid and was worried because it knocked her down; was worried because it knocked her down; couldn't hold anything down; woke every 45 minutes; This is a spontaneous report from a non-contactable consumer (patient). A 7-decade-old patient of an unspecified gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route of administration, administered in Arm Left on 05May2021 14:00 (Batch/Lot Number: Unknown) as dose 2, single for covid-19 immunisation. Medical history included Diagnosed allergies, compromised immune status, respiratory illness, diabetes, obesity, genetic chromosomal abnormalities. The patient's concomitant medications were not reported. The patient previously received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), on 14Apr2021 as dose 1, single for covid-19 immunisation and felt a little tired and her arm hurt (sore arm) about 3-4 days. No other vaccines given the same day as second dose. The caller stated she had the Pfizer Covid-19 vaccine second dose on 05May2021 and had very severe side effects from it. Stated her appointment was for 2pm that Wednesday, 05May2021. She woke up at 4am with severe stomach cramps, dry heaves, low back pain, sweating and drenched with chills throughout the night and woke up every 45 minutes. Had leg cramps, mild sore throat, loss of appetite, neck pain, and was nauseated. Later her face felt itchy and heard about the tiredness and she was very tired, had headaches and felt like she was ran over by a mack truck with no energy. Had waves of severe dry heaves and could not hold anything down. Had nothing to eat the following day and felt horrible. Stated she all these symptoms have improved and the only thing she was concerned about was she still gets the facial itching especially around the chin and cheeks. No hives, but it was almost like a numbness like if you had a shot of Novocain. Further stated she still has no appetite feeling, it was very little and was still tired and worn out. She wondered if these are normal/common after 5 days. She had thought it was the flu or Covid and was worried because it knocked her down. No further details provided. The outcome of Stomach cramps, Dry heaves, Low back pain, Sweating, Chills, Leg cramps, Sore throat, Neck pain, Nauseated, couldn't hold anything down, woke every 45 minutes, Headache, Worry was recovering; Appetite lost, Pruritus facial, Numbness, Energy decreased, Tiredness was not recovered; felt horrible, thought it was the flu or Covid and was worried because it knocked her down was unknown No follow-up attempts are possible. Information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1827967
Sex: F
Age:
State: CA

Vax Date: 05/09/2021
Onset Date: 05/09/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: Chills; Nausea; Soreness in arm; Fatigue; Headache; This is a spontaneous report from a non-contactable consumer, the patient. A 23-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0182) via an unspecified route of administration in the left arm on 09May2021 at 11:00 (at the age of 23-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included naproxen sodium (ALEVE) and ascorbic acid/cyanocobalamin/ergocalciferol/nicotinamide/pyridoxine hydrochloride/retinol/riboflavin/thiamine mononitrate (ONE-A-DAY) gummies; both for unknown indications from unknown date and unknown if on going. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0170) via an unspecified route of administration in the left arm on 18Apr2021 at 12:00 (at the age of 23-years-old) as a single dose for COVID-19 immunisation. On 09May2021 at 21:45, the patient experienced chills, nausea, soreness in arm, fatigue and headache. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chills, nausea, soreness in arm, fatigue and headache was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: ALEVE; ONE-A-DAY [ASCORBIC ACID;CYANOCOBALAMIN;ERGOCALCIFEROL;NICOTINAMIDE;PYRIDOXINE HYDROCHLORIDE;RETINOL

Current Illness:

ID: 1827968
Sex: F
Age:
State: MA

Vax Date: 04/22/2021
Onset Date: 04/22/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: Fever; Body aches; Pins and needles in my hands and feet.; Headache for 4 days; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the left arm on 22Apr2021 at 18:00 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. Medical history included irritable bowel syndrome and COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. Concomitant medication taken within two weeks of vaccination included amitriptyline (MANUFACTURER UNKNOWN) from an unknown date for an unknown indication and unknown if ongoing. The patient previously took metoclopramide (REGLAN) and experienced drug allergy. The patient did not receive any other vaccines within four weeks prior to the vaccination. The most concerning side effect was pins and needles in the patients hands and feet. It started on 22Apr2021 at 20:00, 2 hours after she got her vaccine. It was constant for about 72 hours, and had been off and on daily, since then. Sometimes it would be in other areas, like arms or legs for a few seconds, but mainly it was her hands and feet. The patient also had a headache for 4 days, a fever on 23Apr2021, the day after she got her vaccine, and body aches that lasted about 24 hours. The patient reported she was afraid to get her second dose because she was afraid the pins and needles would get worse. The events resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events fever and body aches were resolved on 24Apr2021 after the duration of 24 hours and headache was resolved on 26Apr2021 after the duration of 4 days, while that of the event pins and needles in hands and feet was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: AMITRIPTYLINE

Current Illness:

ID: 1827969
Sex: F
Age:
State: CA

Vax Date: 03/27/2021
Onset Date: 04/01/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: Brain fog and trouble with short term memory/ It feels like the description of COVID BRAIN FOG but with the vaccine; Trouble with short term memory; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 27Mar2021 at 17:30 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy and cosmetic surgery on 17Mar2021, 10 days before second dose. Prior to the vaccination, it was unknown whether the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included citalopram (MANUFACTURER UNKNOWN), somatropin (HGH), testosterone (MANUFACTURER UNKNOWN), ergocalciferol (VIT D) and multiple (as reported) (MANUFACTURER UNKNOWN); all for unknown indications from unknown dates and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6205) via an unspecified route of administration in the left arm on 25Feb2021 at 14:00 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. On 01Apr2021, about a week or so after second dose, the patient had brain fog and trouble with her short-term memory. The patient thought it might be the anaesthesia and pain pills related to cosmetic surgery, but the brain fog had not gone away at almost 6 weeks. It felt like the description of COVID BRAIN FOG but with the vaccine. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events brain fog and trouble with short term memory/ it feels like the description of COVID BRAIN FOG but with the vaccine and trouble with short term memory was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: CITALOPRAM; HGH; TESTOSTERONE; VIT D [ERGOCALCIFEROL]

Current Illness:

ID: 1827970
Sex: F
Age:
State: IN

Vax Date: 05/11/2021
Onset Date: 05/11/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: Severe body aches; Chills; Fever; Soreness in injection site; Nausea; Loss of appetite; This is a spontaneous report from a contactable consumer, the patient. A 23-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0173) via an unspecified route of administration in the left arm on 11May2021 at 12:00 (at the age of 23-years-old) as a single dose for COVID-19 immunisation. The patient did not have relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the left arm on 20Apr2021 at 10:00 (at the age of 23-years-old) as a single dose for COVID-19 immunisation. On 11May2021 at 23:00, the patient experienced severe body aches, chills, fever, soreness in injection site, nausea and loss of appetite. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events severe body aches, chills, fever, soreness in injection site, nausea and loss of appetite was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1827971
Sex: M
Age:
State:

Vax Date: 05/11/2021
Onset Date: 05/12/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: Tingling pinky finger in arm of vaccination site; Severe sore arm; Muscle aches; This is a spontaneous report from a contactable consumer. A 38-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 11May2021(at the age of 38-years-old) as a single dose for COVID-19 immunisation. The medical history was not reported. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. It was unknown whether the patient received any other vaccines within four weeks prior to the vaccination. It was unknown whether the patient received any other medications within two weeks of the vaccination. On 12May2021, the patient experienced tingling pinky finger in arm of vaccination site, severe sore arm and muscle aches. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. The clinical outcome of the events tingling pinky finger in arm of vaccination site, severe sore arm and muscle aches were unknown at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1827972
Sex: F
Age:
State:

Vax Date: 03/31/2021
Onset Date: 04/02/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: Swelling; This is a spontaneous report form a contactable consumer (Patient) reported that. This is a spontaneous report from a contactable other hcp. A 48-years-old female patient received BNT162B2 (BioNTech/Pfizer vaccine solution for injection), dose 1 via an unspecified route of administration on 31Mar2021 (Batch/Lot number was not reported) as DOSE 1, SINGLE for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient had treated with Restylane to lips and marionette lines and noticed that she had swelling on 02Apr2021, which she thought was normal. On 04Apr2021, she saw no difference. Her before and after looks the same. The event outcome was not recovered. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1827973
Sex: F
Age:
State: GA

Vax Date: 05/10/2021
Onset Date: 05/11/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: This morning I woke up to some little bumps on the side of my face; some little bumps on the side of my face as like in an allergic reaction; This is a spontaneous report from a contactable consumer (patient). A 18-years-old female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EW0162), via an unspecified route on 10May2021 (at the age of 18-years) as dose 2, single in the right arm for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: Unknown), via an unspecified route on 12Apr2021 (at the age of 18-years) as dose 1, single for covid-19 immunisation. On 11May2021, the patient experienced and stated "I received her second vaccine yesterday and this morning I woke up with little dots to some little bumps on the side of my face as like in an allergic reaction. But it was only in the side of my face. It's not where my injection site is or anywhere else in my body, just my face". Patient did not received treatment for events. The outcome of the events was not recovered. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1827974
Sex: F
Age:
State: CO

Vax Date:
Onset Date: 03/19/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: Extreme diarrhea where everything eat and drink comes out as water / Almost immediately after consuming, must be near bathroom or will not make it. It has not let up nor changed forms; Extreme muscle aches; Some vomiting out of the blue; Sweating; Fatigue; This is a spontaneous report from a contactable healthcare professional, the patient. A 52-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via intramuscular route of administration in the right arm on an unknown date at 07:30 as a single dose for COVID-19 immunisation. The patient did not have any medical history. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any medication within two weeks of vaccination. The patient previously received sulfur (MANUFACTURER UNKNOWN) and experienced drug allergy. On 19Mar2021 at 01:00, the patient experienced extreme diarrhea where everything she ate and drank came out as water. Almost immediately after consuming, she must be near bathroom or she will not make it. It had not let up nor changed forms and also had extreme muscle aches, some vomiting out of the blue, sweating and fatigue. The events did not result in a visit to the doctors or other healthcare professional office/clinic, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events extreme diarrhea where everything she ate and drank came out as water, almost immediately after consuming, she must be near bathroom or she will not make it, it had not let up nor changed forms and also had extreme muscle aches, some vomiting out of the blue, sweating and fatigue was not resolved at the time of this report. The patient also received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the right arm on 08Apr2021 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1827975
Sex: F
Age:
State: NY

Vax Date: 05/10/2021
Onset Date: 05/11/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data: Test Date: 20210511; Test Name: Body temperature; Result Unstructured Data: Test Result:101; Comments: Fever of 101 about 24 hours after injection

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: Body aches (severe); Stomach cramping in upper left and right quadrants, resulting in vomiting multiple times over 4+ hours; Stomach cramping in upper left and right quadrants, resulting in vomiting multiple times over 4+ hours; Extreme exhaustion; Dizziness; Shakiness; Nausea; Fever of 101; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 10May2021 at 16:45 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma and know allergies to penicillin (PCN), cephalosporins, almonds and peaches. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient received unspecified concomitant medication on an unknown date, for unknown indication and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 12Apr2021 at 16:45 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. The patient also previously received nitrofurantoin (MACROBID) on an unknown date for unknown indication and experienced drug allergy. On 11May2021 at 06:00, the patient experienced body aches (severe), extreme exhaustion, dizziness, shakiness, nausea and stomach cramping in the upper left and right quadrants, resulting in vomiting multiple times over 4 plus hours. On the same day, about 24 hours after injection the patient experienced a fever of 101 (unspecified units). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events fever of 101 (units unspecified), body aches (severe), extreme exhaustion, dizziness, shakiness, nausea and stomach cramping in upper left and right quadrants, resulting in vomiting multiple times over 4+ hours was resolving at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1827976
Sex: F
Age:
State: MD

Vax Date: 05/10/2021
Onset Date: 05/11/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210511; Test Name: Body temperature test; Result Unstructured Data: Test Result:101.2; Comments: temp 101.2

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: Severe abdominal pain; Vomiting for 4 hours; Temp 101.2; Diarrhea; This is a spontaneous report from a contactable consumer, the patient. A 16-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 10May2021 at 15:45 (at the age of 16-years-old) as a single dose for COVID-19 immunisation. Medical history included reflux and pennecillan allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within 2 weeks of vaccination. The patient previously received azithromycin (Z-PAC) and cefuroxime axetil (CEFTIN) and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 19Apr2021 at 14:30 (at the age of 16-years-old) as a single dose for COVID-19 immunisation. On 11May2021 at 05:30, the patient experienced severe abdominal pain, vomiting for 4 hours over and over, temp 101.2 and diarrhea. On 11May2021, the patient underwent body temperature test and the result was 101.2 (unspecified units). Therapeutic measures were taken as a result of severe abdominal pain, vomiting for 4 hours over and over, temp 101.2 and diarrhea and included treatment with unspecified anti-nausea drugs, acetaminophen and suppositories. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event vomiting for 4 hours over and over was resolved on 11May2021; while that of the events severe abdominal pain, temp 101.2 and diarrhea were resolving at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1827977
Sex: M
Age:
State: PA

Vax Date: 05/05/2021
Onset Date: 05/05/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: Upper back pain beginning on day 5.; Fever for two days after the shot; Severe muscle aches; Skin pain; Headache; This is a spontaneous report from a contactable consumer, the patient. A 27-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the left arm on 05May2021 at 08:45(at the age of 27-years-old) as a single dose for COVID-19 immunisation. Medical history included psoriasis. The patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive other vaccines within four weeks prior to the vaccination. Concomitant medications included triamcinolone acetonide (MANUFACTURER UNKNOWN) for unknown indication from unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration on 14Apr2021 at 08:45(at the age of 27-years-old) as a single dose for COVID-19 immunisation. On 05May2021 at 16:00 the patient experienced fever for two days after the shot, severe muscle aches, skin pain and headache. On 10May2021 the patient experienced upper back pain beginning on day 5. The events did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event fever for two days after the shot was recovered with sequelae on 07May2021 while the events severe muscle aches, skin pain, headache and upper back pain was recovered with sequelae on an unknown date in May2021. No follow-up attempts are needed. No further information is expected.

Other Meds: TRIAMCINOLONE ACETONIDE

Current Illness:

ID: 1827978
Sex: M
Age:
State: TX

Vax Date: 05/05/2021
Onset Date: 05/07/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: Mild to fairly significant brain fog; Difficulty concentrating and remembering things; Difficulty concentrating and remembering things; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0176) via an unspecified route of administration in the left arm on 05May2021 at 13:15 (at the age of-52-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history (no significant conditions). The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included atorvastatin (MANUFACTURER UNKNOWN), lansoprazole (PREVACID), valaciclovir hydrochloride (VALTREX) and montelukast sodium (SINGULAIR) for unknown indication from an unknown date and unknown if ongoing. On 07May2021 at 14:30, the patient experienced mild to fairly significant brain fog, had difficulty concentrating and remembering things. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events brain fog, difficulty concentrating and remembering things were not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: ATORVASTATIN; PREVACID; VALTREX; SINGULAIR

Current Illness:

ID: 1827979
Sex: F
Age:
State: TX

Vax Date: 05/09/2021
Onset Date: 05/11/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: Pain right arm along with a rash on thighs; Pain right arm along with a rash on thighs; This is a spontaneous report from a contactable consumer, the patient. A 22-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0176) via an unspecified route of administration in the right arm on 09May2021 at 12:30 (at the age of 22-years-old), as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included sertraline hydrochloride (ZOLOFT) for unknown indications from unknown date and unknown if ongoing. On 11May2021, the patient experienced pain in right arm along with a rash on thighs. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events pain in right arm along with a rash on thighs were not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: ZOLOFT

Current Illness:

ID: 1827980
Sex: F
Age:
State: KY

Vax Date: 05/10/2021
Onset Date: 05/11/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data: Test Date: 20210511; Test Name: Body temperature; Result Unstructured Data: Test Result:100.4; Comments: Fever 100.4 at 23:00

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: Body aches; Joint pain; Fever 100.4; Nausea; Chills; Severe headache; This is a spontaneous report from a contactable nurse, the patient. A 58-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0179) via an unspecified route of administration in the left arm on 10May2021 at 12:45 (at the age of-58-years-old) as a single dose for COVID-19 immunisation. Medical history included foramen ovale patent (PFO), sleep apnea, hypothyroidism, migraines, arthritis and COVID-19, diagnosed prior to the vaccination. The patient had known allergies (unspecified). The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included duloxetine hydrochloride (CYMBALTA), levothyroxine (MANUFACTURER UNKNOWN), acetylsalicylic acid (ASPIRIN) and butalbital/caffeine/paracetamol (FIORICET); all for unknown indication from an unknown date and unknown if ongoing. On 11May2021 at 23:00, the patient experienced body aches, joint pain, fever 100.4, nausea, chills and severe headache. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events body aches, joint pain, fever 100.4, nausea, chills and severe headache were resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: CYMBALTA; LEVOTHYROXINE; ASPIRIN [ACETYLSALICYLIC ACID]; FIORICET

Current Illness:

ID: 1827981
Sex: F
Age:
State: VA

Vax Date:
Onset Date: 05/01/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: Disruption in menstrual cycle.; This is a spontaneous report from a contactable consumer, the patient. A 16-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on an unknown date in 2021 (at the age of 16-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Concomitant medications included cetirizine hydrochloride (ZYRTEC), unspecified birth control (MANUFACTURE UNKNOWN), ibuprofen (ADVIL), probiotics (MANUFACTURER UNKNOWN) and fish oil (OMEGA 3) taken for unspecified indications, from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 31Mar2021 at 12:00 (at the age of 16-years-old) as a single dose for COVID-19 immunisation. On 01May2021 at 14:00 the patient experienced disruption in menstrual cycle. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event disruption in menstrual cycle was recovered on an unknown date in 2021. No follow-up attempts are needed. No further information is expected.

Other Meds: ZYRTEC [CETIRIZINE HYDROCHLORIDE]; ADVIL [IBUPROFEN]; OMEGA 3 [FISH OIL]

Current Illness:

ID: 1827982
Sex: F
Age:
State: CA

Vax Date: 04/26/2021
Onset Date: 04/26/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210426; Test Name: Body temperature; Result Unstructured Data: Test Result:103.4 Units:[degF]; Comments: fever of 103.4 degrees Fahrenheit; Test Date: 20210501; Test Name: Nasal Swab; Test Result: Negative

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: Unable to move my left arm without excruciating pain; Fever of 103.4 degrees Fahrenheit; Uncontrollable body shaking; Mouth ulcers; Extremely painful headaches; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0170) via an unspecified route of administration in the left arm on 26Apr2021 at 14:00 (at the age of 30-year-old), as a single dose for COVID-19 immunisation. Medical history included Hashimoto's disease and known allergies to latex and reflag (as reported). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient did not receive any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0170) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. The patient previously received hydrocodone (MANUFACTURER UNKNOWN), tramadol (MANUFACTURER UNKNOWN), cefalexin (KEFLEX); all for unknown indications from unknown date and experienced drug allergy. On 26Apr2021 at 17:00, after receiving the second dose of the vaccine, the patient was unable to move the left arm without excruciating pain. Later that evening, the patient experienced a fever of 103.4 degrees Fahrenheit, uncontrollable body shaking, and mouth ulcers. It had been two weeks since receiving the second dose and the patient was still experiencing mouth ulcers and extremely painful headaches. The event resulted in a doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of events which included treatment with paracetamol (TYLENOL). Since the vaccination, the patient had been tested for COVID-19. On 01May2021, the patient underwent lab tests and procedures which included COVID-19 virus test via nasal swab and the result was negative. The clinical outcome of the event unable to move left arm without excruciating pain, fever of 103.4 degrees Fahrenheit, uncontrollable body shaking, mouth ulcers, and extremely painful headaches was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1827983
Sex: F
Age:
State: VT

Vax Date: 04/06/2021
Onset Date: 04/01/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data: Test Name: Blood test; Result Unstructured Data: Test Result:Unknown result; Comments: multiple blood tests; Test Name: XRAY; Result Unstructured Data: Test Result:Unknown result; Test Date: 202104; Test Name: Nasal Swab; Test Result: Negative

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: Within the 2 weeks of "my" 2nd vaccine, "I" experienced bloating, extreme gas pains, diarrhea; Within the 2 weeks of "my" 2nd vaccine, "I" experienced bloating, extreme gas pains, diarrhea; Within the 2 weeks of "my" 2nd vaccine, "I" experienced bloating, extreme gas pains, diarrhea; Three weeks after my second vaccine "I" developed pain in the tops of "my" feet; Three weeks after "my" second vaccine "I" developed pain in the tops of "my" feet, and it gradually increased to swollen ankles, swollen legs, extreme stiffness in ankles, knees, and elbows; Three weeks after "my" second vaccine "I" developed pain in the tops of "my" feet, and it gradually increased to swollen ankles, swollen legs, extreme stiffness in ankles, knees, and elbows; Three weeks after "my" second vaccine "I" developed pain in the tops of "my" feet, and it gradually increased to swollen ankles, swollen legs, extreme stiffness in ankles, knees, and elbows; Red blotches developed on "my" legs that were hot to touch, raised and tender; "I" then developed severe headaches, decreased mobility; "I" then developed severe headaches, decreased mobility; The headaches can be so severe it causes "me" to shiver and chatter "my" teeth; "I" have experienced numbness on "my" bottom lip and chin.; Numbness on "my" bottom lip and chin; The redness and swelling have moved to my right hand; The redness and swelling have moved to "my" right hand; extreme stiffness in ankles, knees, and elbows; Red blotches developed on "my" legs that were hot to touch, raised and tender; Red blotches developed on "my" legs that were hot to touch, raised and tender; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the arm right on 06Apr2021 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. The medical history included hashimoto's hypothyroidism and polycystic ovarian syndrome (PCOS). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medications included levothyroxine/ liothyronine (NP THYROID) for an unknown indication from an unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the arm right on 17Mar2021 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. On an unknown date in Apr2021, within the 2 weeks of second vaccine, the patient experienced bloating, extreme gas pains and diarrhea. On an unknown date in 2021, three weeks after second vaccine, the patient developed pain in the tops of feet and it gradually increased to swollen ankles, swollen legs, extreme stiffness in ankles, knees, and elbows. Red blotches were developed on her legs that were hot to touch, raised and tender. The patient then developed severe headaches and decreased mobility. The headaches was so severe and it caused shiver and chatter her teeth. The patient experienced numbness on the bottom lip and chin. The redness and swelling were moved to her right hand. On an unknown date in Apr2021, the patient underwent SARS-CoV-2 test via nasal swab and the result was negative. On an unknown date, the patient had taken an X-ray and underwent multiple blood tests and the result were unknown. The adverse events resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had been tested for COVID-19. The clinical outcome of the events bloating, extreme gas pains, diarrhea, pain in the tops of feet, swollen ankles, swollen legs, extreme stiffness in ankles, knees, and elbows, red blotches legs that were hot to touch, raised and tender, severe headaches, decreased mobility, the headaches was so severe it causes shiver and chatter teeth, numbness on bottom lip and chin and redness and swelling moved to right hand were not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: NP THYROID

Current Illness:

ID: 1827984
Sex: F
Age:
State: MA

Vax Date: 05/03/2021
Onset Date: 05/04/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Date: 20210111; Test Name: Rapid; Test Result: Negative ; Comments: Nasal swab

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Was on day 2 or 3 when received vaccine. Days 2-4 or 5 are usually heaviest for me. Within 24h ofreceiving vaccine period stopped. Have he period for 20 years. Never this short.; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew0173) via an unspecified route of administration in the right arm on 03May2021 at 10:30 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had known allergy to lactose. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive other vaccines within four weeks prior to the vaccination. The patient received Ok (unspecified) medication within two weeks of vaccination. On 04May2021 at 00:00 the patient's period stopped within 24 hours after receiving vaccine. It was reported that the patient was on day 2 or 3 when she received the vaccine. Days 2-4 or 5 were usually heaviest for her. Within 24 hours of receiving the vaccine, the period stopped. She had her period for 20 years and was never of this short. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had been tested for COVID-19. On 11Jan2021, the patient underwent Rapid COVID-19 virus test (nasal swab) and the result was negative. The clinical outcome of the event within 24 hours of receiving vaccine period stopped was unknown at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1827985
Sex: F
Age:
State: TX

Vax Date: 05/10/2021
Onset Date: 05/11/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Date: 202105; Test Name: Nasal Swab; Result Unstructured Data: Test Result:UNKNOWN RESULT

Allergies:

Symptom List: Nausea

Symptoms: Headache; Body aches; Fever; Dizziness; Diarrhea; Vertigo; This is a spontaneous report from a contactable healthcare professional, the patient. A 25-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 10May2021 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma, allergy to peanuts, peas, mung beans, fava beans, horses, jackfruit. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications taken within two weeks of vaccination included cetirizine hydrochloride (ZYRTEC) and acetylsalicylic acid (ASPIRIN); both for unknown indication from unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on an unknown date as a single dose for COVID-19 immunisation. On 11May2021 at 04:30, the patient experienced headache, body aches, fever, dizziness, diarrhea, vertigo. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had been tested for COVID-19. On unknown date in May2021, the patient underwent COVID-19 test via nasal swab and the result was unknown. Therapeutic measures were taken as a result of the events and included at home treatment with acetylsalicylic acid (ASPIRIN), dextromethorphan hydrobromide, guaifenesin, paracetamol, pseudoephedrine hydrochloride (DAYQUIL), dextromethorphan hydrobromide, doxylamine succinate, ephedrine sulfate, ethanol, paracetamol (NYQUIL). The clinical outcome of the events headache, body aches, fever, dizziness, diarrhea, vertigo was resolving at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: ZYRTEC [CETIRIZINE HYDROCHLORIDE]; ASPIRIN [ACETYLSALICYLIC ACID]

Current Illness:

ID: 1827986
Sex: F
Age:
State: OR

Vax Date: 04/21/2021
Onset Date: 04/22/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: Pronounced exacerbation of benign positional vertigo, such that turning "my" head rapidly (even when seated or laying down) will trigger 30 seconds-1 minute of severe dizziness and related nausea.; Pronounced exacerbation of benign positional vertigo after 2nd dose, such that turning "my" head rapidly (even when seated or laying down) will trigger 30 seconds-1 minute of severe dizziness and related nausea.; Pronounced exacerbation of benign positional vertigo after 2nd dose, such that turning "my" head rapidly (even when seated or laying down) will trigger 30 seconds-1 minute of severe dizziness and related nausea.; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW1072) via an unspecified route of administration in the left arm on 21Apr2021 at 14:15(at the age of 63-years-old) as a single dose for COVID-19 immunisation. The medical history included ehlers-danlos, hashimoto's thyroiditis, reynaud's, chronic migraines, attention deficit hyperactivity disorder (ADHD), obsessive-compulsive disorder (OCD), depression, varicose veins, post-nasal drip, intermittent flare-ups of perioral and periorbital dermatitis, repeated cervical and lumbar spinal injuries, "frayed" R anterior cruciate ligament (ACL), allergies to gluten, casein, dust mite feces and sulfa-based antibiotics are completely ineffective. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. The concomitant medications included atomoxetine (MANUFACTURER UNKNOWN), bupropion (MANUFACTURER UNKNOWN) and unspecified medication of 100 mg, all from unknown dates for unknown indications and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in left arm on 20Mar2021 at 10:30 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. On 22Apr2021 at 09:30, after 2nd dose, the patient experienced pronounced exacerbation of benign positional vertigo, such that turning her head rapidly (even when seated or laying down) would trigger 30 seconds-1 minutes of severe dizziness and related nausea. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events pronounced exacerbation of benign positional vertigo, severe dizziness and related nausea were not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: ATOMOXETINE; BUPROPION

Current Illness:

ID: 1827987
Sex: F
Age:
State: IL

Vax Date: 05/04/2021
Onset Date: 05/04/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Re-emergence of arm pain/Had cortisone shots 7 weeks and 3 weeks prior to vaccine amd was pain-free. Several hours after the shot the pain returned on the left side far more severe than previously. Pain is still severe 9 days after the shot; Bulging cervical disks; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: En6198) via an unspecified route of administration in the left arm on 04May2021, at 11:00 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. Medical history included arm pain, bulging cervical disks and allergy to nickel. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included colecalciferol (VITAMIN D3), calcium (MANUFACTURER UNKNOWN), acetylsalicylic acid (BABY ASPIRIN) and an additional medication (reported as neuroma in the source document); all from an unknown date for unknown indications and unknown if ongoing. The patient previously received cortisone shots (MANUFACTURER UNKNOWN); seven weeks and three weeks prior to vaccine in 2021 for arm pain due to bulging cervical disks and was pain-free. On 04May2021, the patient experienced re-emergence of arm pain due to bulging cervical disks. It was reported that, after several hours of the shot the pain returned on the left side far more severe than previously and the pain was still severe nine days after the shot. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events re-emergence of arm pain due to bulging cervical disks, after several hours of the shot the pain returned on the left side far more severe than previously and the pain was still severe nine days after the shot was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: VITAMIN D3; CALCIUM; BABY ASPIRIN

Current Illness:

ID: 1827988
Sex: M
Age:
State: IN

Vax Date: 04/10/2021
Onset Date: 04/14/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: Dull pain on left side of abdomen that started 3 days after first shot intensified over next three weeks/after the 2nd shot pain started to slowly decrease currently still experiencing it but it's more tolerable; Bloating occured any time I ate anything; Uncomfortable to sit or bend over; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the right arm on 10Apr2021 at 12:00, (at the age of 36-year-old) and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the left arm on an unknown date in 2021, both as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The patient did not receive any concomitant medications. On 14Apr2021 at 12:00, that started 3 days after first shot (as reported), the patient experienced dull pain on left side of abdomen, intensified over next three weeks, bloating occurred any time when the patient ate anything and it was uncomfortable to sit or bend over. After the second shot pain, started to slowly decrease. Currently, (at the time of reporting) patient was still experiencing it but was more tolerable. The events resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. It was unknown whether any therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events dull pain on left side of abdomen, bloating occurred any time when the patient ate anything and uncomfortable to sit or bend over was not resolved at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1827989
Sex: M
Age:
State: NJ

Vax Date: 05/11/2021
Onset Date: 05/11/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210511; Test Name: Body Temperature; Result Unstructured Data: Test Result:(37.8C to 40C); Comments: at 2300; Test Date: 20210105; Test Name: RT PCR; Test Result: Negative ; Comments: Nasal Swab

Allergies:

Symptom List: Tremor

Symptoms: Injection site pain; Recurrent Fever (37.8C to 40C); Myalgia; Arthralgia; Migraine; Insomnia; Light headedness and dizziness; Loss of appetite; Nausea; Sternal chest pain, non-radiating; Tachycardia; Anxiety; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0182) via an unspecified route of administration in the left arm on 11May2021, at 11:00 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Medical history included known allergies to prawn and shrimp. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included vitamins nos and minerals nos (CENTRUM ADULT) and fish oil (MANUFACTURER UNKNOWN); all from an unknown date for unknown indications and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the right arm on 20Apr2021 at 11:00, (at the age of 33-years-old) as a single dose for COVID-19 immunisation. On 11May2021 at 23:00, within 12 hours after vaccination, the patient experienced the following symptoms (in order of occurrence): injection site pain, recurrent fever (37.8C to 40C), myalgia, arthralgia, migraine, insomnia, light headedness and dizziness, loss of appetite, nausea, sternal chest pain, non-radiating, tachycardia and anxiety, and it was reported as the patient had to go on leave from work because of the symptoms. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had been tested for COVID-19. Therapeutic measures were not taken as a result of events. On 05Jan2021, the patient underwent Reverse transcription polymerase chain reaction (RT PCR) nasal swab COVID-19 test, and the result was negative. On 11May2021, the patient underwent body temperature test and the result was 37.8 to 40 degrees centigrade. The clinical outcome of the event recurrent fever (37.8C to 40C) was resolved on 13May2021 while migraine, insomnia, loss of appetite, nausea, anxiety and tachycardia was resolved on an unknown date in May2021. The clinical outcome of the event injection site pain was not resolved while the outcome of myalgia, arthralgia, light headedness and dizziness, sternal chest pain, non-radiating was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: FISH OIL; MINERALS NOS;VITAMINS NOS

Current Illness:

ID: 1827990
Sex: F
Age:
State:

Vax Date: 05/12/2021
Onset Date: 05/13/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: Severe chills; muscle aches; fatigue; nausea; fever; This is a spontaneous report from a non-contactable consumer, the patient. A 33-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0182) via an unspecified route of administration in the left arm on 12May2021 at 13:30 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Medical history included known allergy to avocado (fruit allergy). The patient previously received amoxicillin (MANUFACTURER UNKNOWN) on an unknown date for an unknown indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included spironolactone (MANUFACTURER UNKNOWN), ethinylestradiol/norgestimate (TRI LO ESTARYLLA) and loratidine (CLARITIN); all from an unknown date for unknown indication and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 21Apr2021 at 13:30 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. On 13May2021 at 02:00 the patient experienced severe chills, muscle aches, fatigue, nausea, fever. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of the events and included treatment with ibuprofen (MANUFACTURER UNKNOWN). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event Severe chills, muscle aches, fatigue, nausea, fever were not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: SPIRONOLACTONE; TRI LO ESTARYLLA; CLARITIN [LORATADINE]

Current Illness:

ID: 1827991
Sex: F
Age:
State: MA

Vax Date: 04/09/2021
Onset Date: 05/03/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data: Test Date: 20210512; Test Name: COVID-19 PCR test; Test Result: Negative ; Comments: Nasal Swab

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: "My" menstrual cycle was disrupted. "My" period arrived 9 days earlier than usual, on day 18 of "my" cycle.This has never happened to me. My periodaways arrives on day 27, latest day 29. Never before that.; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 09Apr2021 at 17:30 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any medications within two weeks prior to the vaccination. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER2613) via an unspecified route of administration in the left arm on 19Mar2021 at 17:30 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. On 03May2021, the patient's menstrual cycle was disrupted. The patient's period arrived 9 days earlier than usual, on day 18 of the cycle. This had never happened to the patient. The patient's period always arrived on day 27, latest day would be 29 and never before that. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had been tested for COVID-19. On 12May2021, the patient underwent COVID-19 PCR test via nasal swab and the result was negative. The clinical outcome of the event period arrived 9 days earlier than usual was resolved on an unknown date in May2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1827992
Sex: F
Age:
State: GA

Vax Date: 05/13/2021
Onset Date: 05/13/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: Severe ringing in both ears (tinnutis)within 1 hour of vaccine.; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm on 13May2021 at 16:30 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Medical history included latex allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medication within two weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 22Apr2021 at 09:45 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. On 13May2021 at 17:30, one hour after the vaccination the patient experienced severe ringing in both ears (tinnitus). The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event severe ringing in both ears (tinnitus) was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1827993
Sex: F
Age:
State: GA

Vax Date:
Onset Date:
Rec V Date: 10/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: a little arm pain; This is a spontaneous report from a contactable consumer (Patient). A 49-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included blood pressure from an unknown date and unknown if ongoing. Concomitant medication (other product) included nebivolol hydrochloride (BYSTOLIC) 10 mg, 1x/day taken for blood pressure measurement, start and stop date were not reported. The patient experienced a little arm pain on an unspecified date. The patient stated first one (first dose) was okay for me, it was a little arm pain. The patient received second dose of bnt162b2 on 23Feb2021 for covid-19 immunisation and experienced Fever, Chills and couldn't Sleep. The outcome of event reported as unknown. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: BYSTOLIC

Current Illness:

ID: 1827994
Sex: M
Age:
State:

Vax Date: 05/15/2021
Onset Date: 05/16/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Shortness of breath; High fever; Cough; Swelling in left armpit; Never ending headache.; Inability to quench thirst; This is a spontaneous report from a non-contactable consumer, the patient. A 44-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0185) via an unspecified route of administration in the left arm on 15May2021 at 10:45 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. Medical history included crohn's disease and high cholesterol. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the left arm on 24Apr2021 at 12:45 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. On 16May2021, the patient experienced shortness of breath, high fever, cough, swelling in left armpit, inability to quench thirst, and never ending headache. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events shortness of breath, high fever, cough, swelling in left armpit, inability to quench thirst, and never ending headache was not recovered at the time of report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1827995
Sex: M
Age:
State:

Vax Date: 05/17/2021
Onset Date: 05/17/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: feel pain on the left side which was the injection side of his body; started to get the swollen lumps on that side of the body; Not feeling the best the day on; This is a spontaneous report from a contactable consumer received via Pfizer-sponsored program. A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: unspecified), via an unspecified route of administration on 17May2021 as dose 2, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Historical vaccine included first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: unspecified), via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunization. Reporter stated that she and her husband received the second dose of the COVID vaccine on Monday (17May2021), stated that her husband was not feeling the best the day on. On the next day (18May2021) he started to feel fine and on last night he started to feel pain on the left side which was the injection side of his body and then he started to get the swollen lumps on that side of the body. The clinical outcome was unknown for all events except for event, not feeling the best the day on was recovered on 18May2021. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1827996
Sex: F
Age:
State:

Vax Date: 05/15/2021
Onset Date: 05/16/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210516; Test Name: Heart rate; Result Unstructured Data: Test Result:low 90s; Comments: Increased Time: 10:00; Test Date: 20210516; Test Name: Body temperature; Result Unstructured Data: Test Result:100.7; Comments: Increased Time: 10:00

Allergies:

Symptom List: Pain in extremity

Symptoms: Heart rate in low 90s; Chills; Temp to 100.7; This is a spontaneous report from a non-contactable consumer, the patient. A 57-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0177) via an unspecified route of administration in the arm left on 15May2021 at 16:00 (at the age of 57-years-old), as a single dose for COVID-19 immunisation. Medical history included allergic to sulpha drugs, allergic to raw onions and patient reported she was healthy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medication within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the arm left on 24Apr2021 at 16:00 (age at vaccination: unknown), as a single dose for COVID-19 immunisation. The patient previously had allergy to high doses of erythromycin (MANUFACTURER UNKNOWN). On 16May2021 at 10:00, 18 hours after second dose of vaccination, the patient experienced heart rate in low 90s, chills and temp to 100.7. On 16May2021 at 10:00, the patient underwent body temperature test and the result was found to be 100.7 (unspecified units) and heart rate was found to be low 90s (unspecified units). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events heart rate in low 90s, chills and temp to 100.7 were recovered on an unknown date in May2021. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1827997
Sex: F
Age:
State:

Vax Date: 05/21/2021
Onset Date: 05/22/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: lump on like kind of under my armpit, it is kind of like where my armpit; It is a lump and it is sore; lump on like kind of under my armpit, it is kind of like where my armpit; It is a lump and it is sore; Chills; Headache; Fever; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age received BNT162B2 (formulation: Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on 21May2021 as dose 1, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On 23May2021, the patient experienced lump on like kind of under my armpit, it is kind of like where my armpit; it is a lump and it is sore, on 22May2021 the patient experience chills, headache and fever. It was stated she got the Pfizer shot on Friday and she did experience like chills, headache, and fever all the above, yesterday but then today she has a lump on like kind of under her armpit, it is kind of like where her armpit is and she guess where the strap of her bra meet. Like it is a kind of in that area. It is a lump, and it is sore, and she was just really concerned about. she means she heard about the fever, the chills and stuff like that might occur after vaccination. But she was not aware of the lump. This is the cause for the concern and what should she do. The clinical outcome of the events was unknown. No follow-up attempts are possible; information about batch/lot cannot be obtained.

Other Meds:

Current Illness:

ID: 1827998
Sex: M
Age:
State: OH

Vax Date: 05/22/2021
Onset Date: 05/22/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: Swollen tongue and rash spots on legs and arms; Swollen tongue and rash spots on legs and arms; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 22May2021 at 00:00 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. Medical history included diabetes and known allergies to blood pressure medications. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included insulin glargine (LANTUS), metformin (MANUFACTURER UNKNOWN) and glipizide (MANUFACTURER UNKNOWN) which were taken for diabetes and simvastatin (MANUFACTURER UNKNOWN) taken for unknown indication, all from unknown date and unknown if ongoing. On 22May2021 at 23:00, the patient experienced swollen tongue and rash spots on legs and arms. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events swollen tongue and rash spots on legs and arms were recovering at the time of this report. The lot number for BNT162b2 was not provided and will be requested during follow up.

Other Meds: LANTUS; METFORMIN; GLIPIZIDE; SIMVASTATIN

Current Illness:

ID: 1827999
Sex: F
Age:
State: NY

Vax Date: 06/03/2021
Onset Date: 06/03/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210603; Test Name: Body temperature; Result Unstructured Data: Test Result:~100 degrees fahrenheit; Comments: Fever ~100 degrees Fahrenheit

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: Neck pain; Tingling all over body; achey/weakness all over; achey/weakness all over; severe headache; Fatigue; Lack of appetite; Fever ~100 degrees Fahrenheit; Upper central back pain; Lingering fatigue randomly throughout the following couple days.; inability to lift either arm; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 03Jun2021 at 18:00 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. The medical history included thalassemia (low iron due to small blood cells, similar to anaemia), adult acne, allergy to latex and vinyl. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The concomitant medications included escitalopram (MANUFACTURER UNKNOWN), spironolactone (MANUFACTURER UNKNOWN), ascorbic acid (VIT C), cyanocobalamin (VIT B12) and zinc (MANUFACTURER UNKNOWN), all for unknown indications from unknown dates and unknown if on going. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 13May2021 at 18:30 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. The patient also took previously morphine (MANUFACTURER UNKNOWN) and hydromorphone hydrochloride (DILAUDID) on unknown dates and experienced allergy. On 03Jun2021 at 20:00, for 24 hours, the patient experienced neck pain, tingling all over body and felt as though body got hit by oncoming traffic, achy/weakness all over, inability to lift either arm, severe headache, fatigue, lack of appetite, fever approximately 100 degrees fahrenheit, upper central back pain and lingering fatigue randomly throughout the following couple of days. On the same day, the patient underwent body temperature test and the result was approximately 100 degrees fahrenheit. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events neck pain, tingling all over body, achy/weakness all over, inability to lift either arm, severe headache, fatigue, lack of appetite, fever approximately 100 degrees fahrenheit, upper central back pain and lingering fatigue were resolved with sequelae on an unknown date in Jun2021. The lot number for BNT162b2 was not provided and will be requested during follow up.

Other Meds: ESCITALOPRAM; SPIRONOLACTONE; VIT C; VIT B12; ZINC

Current Illness:

ID: 1828000
Sex: F
Age:
State: NY

Vax Date: 05/20/2021
Onset Date: 05/22/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: Muscle cramping; Twitching in legs and feet about 15-25 Times a day; period is very irregular (has always been regular); This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 20May2021 at 11:00 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to antibiotic. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient received unspecified other medications within 2 weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 22May2021, the patient experienced muscle cramping and twitching in her legs and feet about 15-25 times a day and period was very irregular (had always been regular). The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events muscle cramping, twitching in legs and feet about 15-25 times a day and period was very irregular were not resolved at the time of this report. The lot number for BNT162b2 was not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 1828001
Sex: F
Age:
State: IN

Vax Date: 03/18/2021
Onset Date:
Rec V Date: 10/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: Both vaccines made me start my period early; This is a spontaneous report from a non-contactable consumer, the patient. A 36-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 18Mar2021 at 10:00 (at the age of 36-years-old) as a single dose for COVID-19 immunisation and also received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 08Apr2021 at 10:00 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. Medical history included known allergy to sulfa. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any concomitant medications. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On an unknown date in 2021, the patient experienced both vaccines made her start her period early. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event both vaccines made her start her period early was resolved on an unknown date in 2021. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1828002
Sex: F
Age:
State:

Vax Date: 04/13/2021
Onset Date: 04/13/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: Started menstrual cycle next day and was not due for 20 days/ It was a heavy flow with cramping; Started menstrual cycle next day and was not due for 20 days/ It was a heavy flow with cramping; Ongoing headaches since the vaccine; Taste of metal as soon as shot was administered; This is a spontaneous report from a non-contactable consumer, the patient. A 40-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 13Apr2021 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history and known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The patient did not receive any concomitant medications in two weeks. On 13Apr2021, the patient experienced taste of metal as soon as shot was administered. On 14Apr2021, the patient's menstrual cycle started next day and was not due for 20 days. It was a heavy flow with cramping. The patient had ongoing headaches since the vaccine, three months now. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events taste of metal as soon as shot was administered and started menstrual cycle next day and was not due for 20 days/ it was a heavy flow with cramping was resolved with sequelae (reported as recovered with lasting effects) on an unknown date in 2021. The clinical outcome of the event ongoing headaches since the vaccine was not resolved at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1828003
Sex: F
Age:
State: IN

Vax Date: 06/14/2021
Onset Date: 06/16/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: Started period early after second shot.; Having cramps for the first time and they are very painful.; Diarrhea; This is a spontaneous report from a non-contactable consumer, the patient. A 12-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0191) via an unspecified route of administration in the left arm on 14Jun2021 at 07:30 (at the age of 12-years-old) as a single dose for COVID-19 immunisation. Medical history included occasional migraines. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications taken within two weeks of vaccination included fluticasone propionate (FLONASE) for an unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the left arm on 24May2021 at 08:00 (at the age of 12-years-old) as a single dose for COVID-19 immunisation. On 16Jun2021, the patient started period early after second shot. She was having cramps for the first time and they are very painful. The patient also had diarrhea. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events started period early after second shot; she was having cramps for the first time and they are very painful and diarrhea was not resolved at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds: FLONASE [FLUTICASONE PROPIONATE]

Current Illness:

ID: 1828004
Sex: M
Age:
State: NC

Vax Date: 05/07/2021
Onset Date: 05/10/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: Nausea; Vomiting; Diarrhea; Headaches; Dizziness; Tingling in the hands arms legs feet; This is a spontaneous report from a contactable consumer, the patient. A 25-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0182) via an unspecified route of administration in the left arm on 07May2021 at 14:30 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. On 10May2021 at 13:15, the patient experienced nausea, vomiting, diarrhea, headaches, dizziness and tingling in the hands arms legs feet. The events resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. It was unknown whether therapeutic measures were taken as a result of the events. The clinical outcome of the events, nausea, vomiting, diarrhea, headaches, dizziness and tingling in the hands arms legs feet were not resolved at the time of this report.

Other Meds:

Current Illness:

ID: 1828005
Sex: F
Age:
State: CO

Vax Date: 06/14/2021
Onset Date: 06/14/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: Altered taste; Tongue burning; Nausea; Shakes; Chills; Injection site redness; Pain; Weakness; Extreme fatigue; This is a spontaneous report from a contactable nurse, the patient. A 54-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0196) via an unspecified route of administration in the left arm on 14Jun2021 at 12:00 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. Medical history included allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included cetirizine hydrochloride (ZYRTEC) and multivitamin (MANUFACTURER UNKNOWN); both for an unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0182) via an unspecified route of administration in the left arm on an unknown date in May2021 at 16:30 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. The patient previously also received methylparaben (MANUFACTURER UNKNOWN) for unknown indication from an unknown date and experienced drug allergy. On 14Jun2021 at 12:30, the patient experienced altered taste, tongue burning, nausea, shakes, chills, injection site redness, pain, weakness and extreme fatigue. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the events. The clinical outcome of the events shakes, chills, injection site redness, pain, weakness and extreme fatigue was resolved on an unknown date in Jun2021 whereas events altered taste, tongue burning and nausea was not resolved at the time of this report on 21Jun2021.

Other Meds: ZYRTEC [CETIRIZINE HYDROCHLORIDE]

Current Illness:

Total 2021 VAERS Injuries: 654,986

Page last modified: 13 November 2021 9:17am